Scentech Medical develops noninvasive real-time screening solutions for infectious diseases, providing instant results using a simple breath test. The company's technology detects the presence of unique metabolic processes associated with pathogens. Each pathogen has a different genetic expression that creates a singular metabolic fingerprint, enabling Scentech Medical's Rapid Scent Test to identify different pathogens even in the early stages of infection when patients may be asymptomatic. Scentech Medical is owned by parent company Scentech and other investors.